Project Details
| Status | Active |
|---|---|
| Effective start/end date | 8/23/24 → 8/23/31 |
Funding
- Quintiles, Inc. (Prot #CL3-95031-007 // Prot #CL3-95031-007)
- Servier Bio-Innovation LLC (Prot #CL3-95031-007 // Prot #CL3-95031-007)
Prot #CL3-95031-007: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Ivosidenib in Participants ≥18 Years of Age with Locally Advanced or Metastatic Conventional Chondrosarcoma with an IDH1 Mutation, Untreated or Previously
Project: Research project